Verteporfin Market Growth Is Driven by Increasing Incidence of Severe Eye Conditions


Verteporfin is a medication used to eliminate the abnormal blood vessels in the eye associated with conditions such as the wet form of macular degeneration. Along with laser light treatment, it is used for the treatment of severe eye conditions, such as ocular histoplasmosis, pathologic myopia, and macular degeneration. Moreover, verteporfin is extensively used to help prevent decreased vision and blindness. It is administered intravenously before 15-20 minutes of photo dynamic treatment. After the injection of verteporfin, doctor will use laser light treatment on the affected eye(s). The laser light will convert the drug into a form that works by damaging only the cells that cause serious eye problems.

Thus, with the increasing incidence of severe eye conditions, such as ocular histoplasmosis, pathologic myopia, and macular degeneration, demand for verteporfin is also increasing with a rapid pace, driving the growth of the verteporfin market. According to the World Health Organization (WHO), pathologic myopia causes more vision impairment/blindness in Asians than in Caucasians. Overall vision impairment due to pathologic myopia occurs in 5 to 10 Asian people per 100,000 annually. Asia accounts for around 60% of the world population, and thus, will see the largest projected number of cases of age-related macular degeneration (AMD) and will increase more rapidly than other regions, despite having the lowest prevalence currently.

This in turn is expected to augment the growth of the verteporfin market, especially in the Asia Pacific. Verteporfin is used in combination with photodynamic therapy (PDT) for the treatment of abnormal growth of leaky blood vessels in the eye caused by wet AMD, pathologic myopia, or histoplasmosis of the eye. Moreover, the demand for verteporfin has also increased due to diversified use of verteporfin in various applications of ophthalmology, driving the verteporfin market growth. Thus, to meet the increasing demand, market players are focusing on launching new products for the use of verteporfin in ophthalmology.

For instance, in 2019, CIBA Corporation received authorization, from the European Medicine Evaluation Agency, for the marketing of verteporfin therapy for choroidal neovascularization. The European Medicines Agency is an agency of the European Union (EU) in charge of the evaluation and supervision of medicinal products. Photodynamic therapy with verteporfin has been tested for treatment of several human cancer, such as metastatic breast cancer, pancreatic cancer, and posterior uveal melanoma. Furthermore, research institutes are focused on applying verteporfin in oncology treatments, which in turn is also expected to accelerate the growth of the verteporfin market.

Comments

Post a Comment

Popular posts from this blog

U.S. Meibomian Gland Dysfunction Market is growing rapidly with ThermaMEDx introducing a self-healing, disposable, pre-moistened, sterile cleaning eye-pad for use in treating the symptoms of dry eyes and meibomian gland dysfunction

Image
Dysfunction of any of these three glands can result in Meibomian gland dysfunction. A primary cause for this condition is not really the disease itself but rather the abnormal overproduction of sebum (the secreted liquid of glands). This is normally controlled by the hypothalamus-pituitary gland system which inhibits the secretion of oil. Rapidly increases the prevalence of meibomian gland dysfunction remains one of the critical factors aiding the development of the market. In fact, as per the Fellow of American College of Surgeons, meibomian gland disease, is one of the most common causes of dry eyes and around 50-70% of the elderly population has some degree of dry eye. Besides, as per the American Optometric Association’s study in 2017, over 16 million people in the U.S. were suffering from dry eye disease. Such factors can indeed stimulate growth of the U.S. meibomian gland dysfunction market. When it comes to the drug type, Cyclosporine segment seems to be exhibiting positive trac...
Read more

Boston Sci Launched A New Device For Erectile Dysfunction Devices Market

Image
  North America is expected to hold the major share in the global erectile dysfunction devices market and this is attributed to the continuous innovation in the device by key players in the region. For instance, in July 2019, Boston Scientific announced the launch of the Tactra penile implant, which is a durable implant with a natural feel for treating ED. Also, in August 2019, Ohio, U.S.-based Integrated Medical announced that they are offering a state-of-the-art Extra Corporeal Shock Wave Therapy (ESWT) for treating ED. The therapy will utilize power generated through acoustic sound waves and radial shockwaves to stimulate neovascularization The growing prevalence of cardiovascular or diabetes disease among men undergoing such treatment are at higher risk of developing erectile dysfunction. This is driving the growth of the  erectile dysfunction devices market . Vacuum pumps, also known as Vacuum Erection devices (VED) are gaining huge demand around the globe. According to t...
Read more

Bakeable Trays Market Estimated To Develop At Cagr at 4.8% During Estimate Duration 2019-2027

Image
The expansion of direct bundle to-broiler pastry shop items have pushed the market for bakeable trays. While these items have been around for some time, the rise of new sorts of bakeable trays features the market's development as of late. Contrasted with the conventional preparing trays which are comprised of metal, the bakeable trays are produced using a ridged paper card board that is both warmth safe and water confirmation. Such trays are made to withstand temperatures up to 220°C. These bakeable or ovenable trays are offered in various sizes and shapes. Bakeable trays can even be tweaked for various end use applications. One of the differentiating highlights of bakeable trays is that they are made of bio-degradable substance and are recyclable. These are likewise endorsed by different food organizations for direct food contact making it more secure to buyer straightforwardly from them. The worldwide  bakeable trays market  is required to arrive at US$ 1,943.8 million by 20...
Read more